Takeda Pharmaceutical TAK
NYSE TAK
$18.48 -0.42 (-2.22%)
As of: Sep 29, 2026 · 3:59 PM EDT

Takeda Pharmaceutical (TAK) EBT (2017 - 2026)

Updated

Takeda Pharmaceutical (TAK) recorded EBT of $1.02 billion in the quarter ended Jun 30, 2026, down 1.9% from $1.04 billion a year earlier and down 1.6% from the prior quarter.

Analysis

Takeda Pharmaceutical (TAK) EBT (2017 - 2026) Analysis & Trends

On a TTM basis, Takeda Pharmaceutical's EBT came in at $1.22 billion as of Jun 30, 2026, down 61.9% year-over-year; for the year ended Mar 31, 2026, it was -$945.69 million.

  • Across earlier years, EBT came in at $1.15 billion in the year ended Mar 31, 2025 (+214.0%), $366.06 million in the year ended Mar 31, 2024 (-86.8%), $2.78 billion in the year ended Mar 31, 2023 (+3.0%) and $2.69 billion in the year ended Mar 31, 2022 (-22.0%).
  • Quarterly EBT has ranged from -$2.96 billion in the quarter ended Dec 31, 2025 to $2.27 billion in the quarter ended Sep 30, 2023 over the past five years.
  • On a year-over-year basis, EBT rose in four of the last six quarters, with growth averaging 4.1%.
  • Peak year-over-year performance for EBT in the last five years was growth of 384.8% in the quarter ended Sep 30, 2023, against a decline of 57.3% in the quarter ended Dec 31, 2023 at the low end.
  • Per Business Quant, the preceding three quarters came in at $1.04 billion (quarter ended Mar 31, 2026), -$2.96 billion (quarter ended Dec 31, 2025) and $2.12 billion (quarter ended Sep 30, 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 6.75 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 4.28 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn -683.00 Mn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 4.27 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 2.80 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 2.77 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn -10.25 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn -653.00 Mn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 1.39 Bn
10 Takeda Pharmaceutical 2.74 Bn -23.77 Bn 5.10 Bn 1.02 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.02 Bn
Mar 31, 2026 1.04 Bn
Dec 31, 2025 -2.96 Bn
Sep 30, 2025 2.12 Bn
Jun 30, 2025 1.04 Bn
Mar 31, 2025 987.12 Mn
Dec 31, 2024 -705.80 Mn
Sep 30, 2024 1.89 Bn
Jun 30, 2024 877.53 Mn
Mar 31, 2024 921.75 Mn
Dec 31, 2023 324.05 Mn
Sep 30, 2023 2.27 Bn
Jun 30, 2023 985.33 Mn
Mar 31, 2023 1.18 Bn
Dec 31, 2022 758.46 Mn
Sep 30, 2022 467.37 Mn
Jun 30, 2022 1.20 Bn
Mar 31, 2022 1.92 Bn
Jun 30, 2021 2.04 Bn
Mar 31, 2021 2.11 Bn
API Access

Takeda Pharmaceutical EBT API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebt&ticker=TAK&period=max&api_key=YOUR_API_KEY